Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    Antioxidant | Open Studies | Exclude Unknown | NCCAM
Show Display Options
RSS Create an RSS feed from your search for:
Antioxidant | Open Studies | Exclude Unknown | NCCAM
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
2 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
3 Not yet recruiting Resveratrol to Enhance Vitality and Vigor in Elders
Conditions: Mitochondrial Function;   Physical Function
Interventions: Drug: Resveratrol 1000 mg/day;   Drug: Resveratrol 1500 mg/day;   Other: Vegetable cellulose;   Other: All groups
4 Recruiting Lipoic Acid and Prevention of Heart Disease
Condition: Atherosclerosis
Interventions: Dietary Supplement: R-alpha lipoic acid;   Dietary Supplement: Placebo
5 Recruiting The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease
Condition: Atherosclerosis
Intervention: Dietary Supplement: Crossover of R-alpha lipoic acid and placebo
6 Not yet recruiting Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Meganatural-Az Grapeseed Extract;   Drug: Placebo

Indicates status has not been verified in more than two years